S&P 500   5,139.55 (+0.32%)
DOW   38,131.90 (+0.39%)
QQQ   438.72 (+0.10%)
AAPL   175.49 (-0.60%)
MSFT   422.16 (+0.06%)
META   508.96 (-0.57%)
GOOGL   158.42 (+0.44%)
AMZN   186.72 (+0.32%)
TSLA   166.77 (-2.50%)
NVDA   889.64 (+0.88%)
AMD   162.93 (-0.21%)
NIO   3.95 (-3.89%)
BABA   71.33 (+0.06%)
T   16.36 (+0.31%)
F   12.47 (-1.11%)
MU   123.79 (+1.04%)
GE   155.08 (+0.29%)
CGC   7.30 (-6.41%)
DIS   114.20 (+0.17%)
AMC   2.61 (-1.51%)
PFE   26.07 (+0.81%)
PYPL   64.79 (+0.31%)
XOM   120.64 (+0.22%)
S&P 500   5,139.55 (+0.32%)
DOW   38,131.90 (+0.39%)
QQQ   438.72 (+0.10%)
AAPL   175.49 (-0.60%)
MSFT   422.16 (+0.06%)
META   508.96 (-0.57%)
GOOGL   158.42 (+0.44%)
AMZN   186.72 (+0.32%)
TSLA   166.77 (-2.50%)
NVDA   889.64 (+0.88%)
AMD   162.93 (-0.21%)
NIO   3.95 (-3.89%)
BABA   71.33 (+0.06%)
T   16.36 (+0.31%)
F   12.47 (-1.11%)
MU   123.79 (+1.04%)
GE   155.08 (+0.29%)
CGC   7.30 (-6.41%)
DIS   114.20 (+0.17%)
AMC   2.61 (-1.51%)
PFE   26.07 (+0.81%)
PYPL   64.79 (+0.31%)
XOM   120.64 (+0.22%)
S&P 500   5,139.55 (+0.32%)
DOW   38,131.90 (+0.39%)
QQQ   438.72 (+0.10%)
AAPL   175.49 (-0.60%)
MSFT   422.16 (+0.06%)
META   508.96 (-0.57%)
GOOGL   158.42 (+0.44%)
AMZN   186.72 (+0.32%)
TSLA   166.77 (-2.50%)
NVDA   889.64 (+0.88%)
AMD   162.93 (-0.21%)
NIO   3.95 (-3.89%)
BABA   71.33 (+0.06%)
T   16.36 (+0.31%)
F   12.47 (-1.11%)
MU   123.79 (+1.04%)
GE   155.08 (+0.29%)
CGC   7.30 (-6.41%)
DIS   114.20 (+0.17%)
AMC   2.61 (-1.51%)
PFE   26.07 (+0.81%)
PYPL   64.79 (+0.31%)
XOM   120.64 (+0.22%)
S&P 500   5,139.55 (+0.32%)
DOW   38,131.90 (+0.39%)
QQQ   438.72 (+0.10%)
AAPL   175.49 (-0.60%)
MSFT   422.16 (+0.06%)
META   508.96 (-0.57%)
GOOGL   158.42 (+0.44%)
AMZN   186.72 (+0.32%)
TSLA   166.77 (-2.50%)
NVDA   889.64 (+0.88%)
AMD   162.93 (-0.21%)
NIO   3.95 (-3.89%)
BABA   71.33 (+0.06%)
T   16.36 (+0.31%)
F   12.47 (-1.11%)
MU   123.79 (+1.04%)
GE   155.08 (+0.29%)
CGC   7.30 (-6.41%)
DIS   114.20 (+0.17%)
AMC   2.61 (-1.51%)
PFE   26.07 (+0.81%)
PYPL   64.79 (+0.31%)
XOM   120.64 (+0.22%)

Artelo Biosciences (ARTLW) Competitors

$0.02
0.00 (0.00%)
(As of 04/12/2024 ET)

ARTLW vs. ATNFW, SXTPW, DRTSW, APLMW, BCDAW, BCTXW, CDIOW, CTCXW, SAVAW, and CELUW

Should you be buying Artelo Biosciences stock or one of its competitors? The main competitors of Artelo Biosciences include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

Artelo Biosciences vs.

Artelo Biosciences (NASDAQ:ARTLW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Artelo Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
Artelo BiosciencesN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Artelo Biosciences. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for Artelo Biosciences. Artelo Biosciences' average media sentiment score of 1.89 beat 180 Life Sciences' score of 0.43 indicating that Artelo Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Artelo Biosciences Very Positive
180 Life Sciences Neutral

Artelo Biosciences and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Artelo BiosciencesN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Artelo BiosciencesN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Artelo Biosciences and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.

Get Artelo Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARTLW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ARTLW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARTLW vs. The Competition

MetricArtelo BiosciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$371.53M$4.68B$7.58B
Dividend YieldN/A3.48%5.42%3.94%
P/E RatioN/A218.85243.9419.29
Price / SalesN/A12,391.522,387.35102.19
Price / CashN/A12.0734.0930.92
Price / BookN/A5.434.574.49
Net IncomeN/A-$37.60M$98.74M$211.63M
7 Day PerformanceN/A8.20%109.74%-1.56%
1 Month PerformanceN/A7.09%115.07%3.05%
1 Year PerformanceN/A62.67%138.27%8.98%

Artelo Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-56.0%$0.00N/A0.004Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.11
flat
N/AN/A$0.00$90,718.000.002Positive News
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.26
+4.0%
N/A-6.3%$0.00N/A0.00121Short Interest ↓
Gap Up
APLMW
Apollomics
0 of 5 stars
$0.03
flat
N/AN/A$0.00N/A0.0059Short Interest ↑
BCDAW
BioCardia
0 of 5 stars
$0.03
+50.5%
N/AN/A$0.00$477,000.000.0030Gap Up
BCTXW
BriaCell Therapeutics
0 of 5 stars
$1.08
-12.9%
N/A-63.1%$0.00N/A0.0016Gap Down
High Trading Volume
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.08
+14.3%
N/AN/A$0.00$17,065.000.007Gap Up
CTCXW
Carmell
0 of 5 stars
$0.15
flat
N/AN/A$0.00$3.73M0.009Positive News
Gap Up
SAVAW
Cassava Sciences
0 of 5 stars
$6.17
+38.6%
N/AN/A$0.00N/A0.0029Gap Up
CELUW
Celularity
0 of 5 stars
$0.05
flat
N/A-20.0%$0.00$14.79M0.00225

Related Companies and Tools

This page (NASDAQ:ARTLW) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners